MEDISANA Supervisory Board appoints Marco Getz as CFO
MEDISANA Supervisory Board appoints Marco Getz as CFO*MEDISANA Supervisory Board appoints Marco Getz as CFO -*
*Hubertus A. Peels leaves the Management Board*
Hilden, 17 September 2007 – Following the success of the strategic realignment of the company and the positive business performance in HY1 2007 which this consolidated, MEDISANA AG has taken further steps to herald in a successful future. Signs at MEDISANA point to acceleration of the profitable growth rate, both in Germany and as well as now abroad, and to strengthening of the Controlling business division and Investor Communication.
The Supervisory Board has appointed Mr Marco Getz (36) as CFO of MEDISANA AG. He will take up this office on 1 October 2007. Mr Getz has been head of the Accounting Department at MEDISANA AG since September 2004, where he successfully implemented improvements to the reporting system, installed a controlling system in all divisions of the group and identified areas exhibiting cost saving potential.
Hubertus A. Peels, member of the Management Board at MEDISANA AG in charge of sales outside Germany and supervision of sales subsidiaries abroad excluding the USA, is leaving the company on 30 September 2007 following the expiration of his Board of Management contract. “We wish to thank Mr Peels for his dedication and the contribution he made to the company,” says Dr Matthias Hartz, Chairman of the Supervisory Board at MEDISANA AG. “We are now looking forward to working together with Mr Marco Getz. Mr Getz is an experienced, dynamic corporate finance expert. We are convinced that the new Finance Department will strengthen the operating vigour of the company,” continues Dr Hartz.
Accompanying the changes in the Management Board, responsibilities within the management committee will be rearranged as of 1 October 2007.
Ralf Lindner, CEO, will now be in charge of all markets worldwide, Marco Getz will be in charge of finance, controlling and administration.
*Nächster Finanztermin 2007:*
22. November 2007 Zwischenmitteilung zum 3. Quartal 2007
Tel.: 02103-200 7-60
Fax: 02103-200 7-10
Weitere Informationen zum Unternehmen sowie zum Produkt-Portfolio finden Sie unter: